Senseonics Holdings, Inc., a medical tech company specializing in implantable glucose monitoring systems, has closed a public offering raising $92 million. The company sold 10.4 million common shares, including 2.4 million additional shares from the underwriters’ option, plus 8 million pre-funded warrants. The proceeds will support the development and commercialization of their long-term glucose monitoring products. This financing strengthens Senseonics' position in the diabetes care market as it advances its technology and expands its offerings.
The IBIT Bitcoin ETF, managed by BlackRock, recorded a $292 million net inflow last week, reversing eight consecutive weeks of outflows. This inflow reflects renewed institutional interest in Bitcoin, which currently trades near $70,000. Market confi...
After a 72% price drop, XRP has reached extreme bearish sentiment, with heavy short interest and negative funding rates on Binance. Analysts like Crypto Patel see this as a contrarian buy signal, noting past rebounds of over 100% after similar condit...
Bitcoin is approaching the lower support line of a power-law price model Fidelity has tracked since 2015, currently near $58,000. This line has historically marked major bottoms, suggesting Bitcoin is entering an accumulation zone. However, Fidelity'...
Jurrien Timmer, Fidelity's global macro director, suggests Bitcoin may have reached a critical support level around $60,000, indicating it could be in an accumulation zone. This assessment is based on a power law model that historically marks buying ...
Mark Lanier won a landmark $6 million verdict against Meta and Google, proving their platforms were designed to be addictive and harmful to children's mental health. The case, led by a young plaintiff named Kaley, exposed internal documents showing d...
